1. Home
  2. TIVC vs CANF Comparison

TIVC vs CANF Comparison

Compare TIVC & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tivic Health Systems Inc.

TIVC

Tivic Health Systems Inc.

HOLD

Current Price

$1.52

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$0.20

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIVC
CANF
Founded
2016
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
2.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TIVC
CANF
Price
$1.52
$0.20
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.25
AVG Volume (30 Days)
2.6M
10.0M
Earning Date
11-14-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$482,000.00
$560,000.00
Revenue This Year
N/A
$461.72
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$0.17
52 Week High
$15.64
$2.33

Technical Indicators

Market Signals
Indicator
TIVC
CANF
Relative Strength Index (RSI) 35.79 35.71
Support Level $1.40 $0.17
Resistance Level $1.60 $0.27
Average True Range (ATR) 0.26 0.03
MACD -0.05 -0.00
Stochastic Oscillator 3.85 21.60

Price Performance

Historical Comparison
TIVC
CANF

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).

Share on Social Networks: